Readystate Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$703K Buy
+2,400
New +$789K 0.03% 482
2025
Q1
Sell
-15,000
Closed -$5.53M 641
2024
Q4
$5.53M Sell
15,000
-13,700
-48% -$5.73M 0.17% 130
2024
Q3
$14.9M Buy
28,700
+27,600
+2,509% +$14.7M 0.28% 116
2024
Q2
$596K Sell
1,100
-19,300
-95% -$10.2M 0.02% 471
2024
Q1
$10.6M Buy
+20,400
New +$10.1M 0.15% 164

Other funds holding ELV

Readystate Asset Management's ELV Position: Q1 2025 in Review

Readystate Asset Management sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 7,839 shares — an estimated $2.89M sold.

Readystate Asset Management first reported a position in ELV in Q3 2024 and held it in 2 quarters. The position peaked at $3.17M in Q3 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Readystate Asset Management reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Readystate Asset Management sold 7,839 Elevance Health shares in Q1 2025, an estimated $2.89M.
  • Readystate Asset Management first reported a position in Elevance Health in Q3 2024 and held it in 2 quarters.
  • Readystate Asset Management's Elevance Health position peaked at $3.17M in Q3 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Readystate Asset Management's 13F filing for Q1 2025, filed 6 May 2025.